secwatch.observer — SEC 8-K summary
======================================

Issuer:     Tarsus Pharmaceuticals, Inc. (TARS)
CIK:        0001819790
Form:       8-K
Filed at:   2025-01-17T23:59:59+00:00
Accession:  0001819790-25-000003
Event type: leadership
Sentiment:  neutral
Materiality: 0.40
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Tarsus board member Rosemary Crane resigns, becomes consultant; committee changes
--------------------------------------------------------------------------------

- Rosemary Crane resigned from Board and committees effective Jan 17, 2025; not due to any disagreement.
- Crane entered a 6-month consulting agreement with Tarsus, continuing to vest in equity awards.
- Wendy Yarno appointed Chairperson of Commercial Committee; steps off Audit Committee effective Jan 17.
- Andrew Goldberg, M.D. appointed to Audit Committee effective Jan 17, 2025.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1819790/000181979025000003/0001819790-25-000003-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1819790/000181979025000003/tars-20250115.htm
  HTML page:      https://secwatch.observer/filing/0001819790-25-000003

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer